Clinical, electrophysiologic and antiarrhythmic efficacy of moricizine HCl
- 1 October 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (11) , 40-44
- https://doi.org/10.1016/0002-9149(87)90719-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ethacizin: A new efficacious Soviet antiarrhythmic drug of the phenothiazine groupAmerican Heart Journal, 1986
- Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardiaAmerican Heart Journal, 1984
- Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndromeAmerican Heart Journal, 1984
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safetyAmerican Heart Journal, 1983
- Persistent sinus nodal electrograms during abnormally prolonged postpacing atrial pauses in sick sinus syndrome in humans: sinoatrial block vs overdrive suppression.Circulation, 1983
- Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation, 1980
- Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and toleranceAmerican Heart Journal, 1979
- Electrophysiological effects of ethmozin on canine myocardiumCardiovascular Research, 1979
- “Paradoxical” prolongation of sinus nodal recovery time after atropine in the sick sinus syndromeThe American Journal of Cardiology, 1975